Alex Jaksch, Director- WW Strategic Marketing, Safety, BD Medical-Pharmaceutical Systems apprised the audience on the needlestick legislation which could possibly be the differentiator for companies eyeing the exports and domestic markets.
Murli Sundrani, Business Director- BD Medical-Pharmaceutical Systems – India said, “With more than 115 years of expertise in manufacturing and processing technology for parenteral drug delivery systems, BD understands how best to meet the pharmaceutical industry’s delivery requirements for injectable medications. BD’s expanded presence in safety technologies demonstrates our commitment to developing innovative solutions that help address our customers’ unmet needs. We are glad that Technovation Seminar is able to bring forth the expertise and share knowledge with our esteemed customers.”
Tom Koning, Director- WW Commercial Development, Safety, BD Medical-Pharmaceutical Systems elaborated on the portfolio of BD Safety & Needle Shielding Systems.
EP News Bureau – Mumbai